Chang and coworkers searched for autoantibodies in hospitalized patients with COVID-19 and found that approximately 50% of hospitalized patients developed autoantibodies against one or more antigens in the array they tested for with 25% of patients being ANA positive [104]. The gene discussed is BTG3; the disease is COVID-19.